The commentary below transcribes Cabra's existing summary PDF. It preserves the original analysis, including its checklist and wording. The original PDF remains available below. Advisory opinions concern their particular facts and requestors; this commentary is not legal advice.
What OIG Said
OIG said gainsharing payments can be OK if they’re set in advance, tied to documented clinical value, and capped by fair market metrics.
✓A hospital created a 3-year gainsharing program where neurosurgeons earned a share of cost savings from reducing surgical supply spend and limiting BMP use, without cutting medically necessary services.
✓OIG acknowledged the payments as “remuneration,” so Anti-Kickback was in play, but accepted the program because payments were per capita, capped, and tied to verified cost reductions.
✓OIG noted the payments were calculated annually, rebased each year, and capped at 50% of expected savings, with documentation showing no link to referral volume or patient steering.
✓A third-party administrator ran the analysis and FMV certifications, and a multi-party oversight committee monitored quality and case mix to guard against cherry-picking or under-treatment.
OIG WATCH | info@cabraconsulting.com
Diligence Checklist
What you need to be ready to show in diligence
✓Have a third-party perform and document benchmarking and FMV validation for all incentive payments.
✓Prove your savings calculations are rebased annually and exclude volume growth from Federal payors.
✓Show that physician incentives are per capita, capped, and tied to defined cost-saving actions, not referrals or collections.
✓Maintain documentation that all changes are clinically supported, with oversight verifying no reduction in necessary care.
✓Disclose the payment structure to patients and retain proof of that notice.
If your shared savings program can’t prove FMV, clinical necessity, and independence from referrals, it’s not defensible, and it’s the profile OIG reviewed here.
OIG WATCH | info@cabraconsulting.com
Structure not diligence-ready?
Cabra Consulting helps healthcare organizations make sure compensation and transaction structures are independently valued, clearly scoped, and defensible in diligence.
OIG WATCH | info@cabraconsulting.com
Original PDF cover text
FAVORABLE
OIG WATCH
17-09
Physician gainsharing for surgical supply savings
Cabra commentary publication date is not recorded in the existing source. No publication or revision date has been inferred from this HTML conversion.
The commentary below transcribes Cabra's existing summary PDF. It preserves the original analysis, including its checklist and wording. The original PDF remains available below. Advisory opinions concern their particular facts and requestors; this commentary is not legal advice.
What OIG Said
OIG said gainsharing payments can be OK if they’re set in advance, tied to documented clinical value, and capped by fair market metrics.
✓A hospital created a 3-year gainsharing program where neurosurgeons earned a share of cost savings from reducing surgical supply spend and limiting BMP use, without cutting medically necessary services.
✓OIG acknowledged the payments as “remuneration,” so Anti-Kickback was in play, but accepted the program because payments were per capita, capped, and tied to verified cost reductions.
✓OIG noted the payments were calculated annually, rebased each year, and capped at 50% of expected savings, with documentation showing no link to referral volume or patient steering.
✓A third-party administrator ran the analysis and FMV certifications, and a multi-party oversight committee monitored quality and case mix to guard against cherry-picking or under-treatment.
OIG WATCH | info@cabraconsulting.com
Diligence Checklist
What you need to be ready to show in diligence
✓Have a third-party perform and document benchmarking and FMV validation for all incentive payments.
✓Prove your savings calculations are rebased annually and exclude volume growth from Federal payors.
✓Show that physician incentives are per capita, capped, and tied to defined cost-saving actions, not referrals or collections.
✓Maintain documentation that all changes are clinically supported, with oversight verifying no reduction in necessary care.
✓Disclose the payment structure to patients and retain proof of that notice.
If your shared savings program can’t prove FMV, clinical necessity, and independence from referrals, it’s not defensible, and it’s the profile OIG reviewed here.
OIG WATCH | info@cabraconsulting.com
Structure not diligence-ready?
Cabra Consulting helps healthcare organizations make sure compensation and transaction structures are independently valued, clearly scoped, and defensible in diligence.
OIG WATCH | info@cabraconsulting.com
Original PDF cover text
FAVORABLE
OIG WATCH 17-09
Physician gainsharing for surgical supply savings
Cabra commentary publication date is not recorded in the existing source. No publication or revision date has been inferred from this HTML conversion.